GG
Therapeutic Areas
Pinion Immunotherapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ARV-2001 | HPV-16 Precancer | Preclinical |
| DCAR-001 | AML Immunotherapy | Preclinical |
| ARV-1004 | EBV Therapeutic | Preclinical |
| ARV-1003 | HBV Therapeutic | Preclinical |
| Undisclosed | HSV Therapeutic | Preclinical |
Leadership Team at Pinion Immunotherapeutics
RX
Renhuan Xu, PhD
CSO, Co-founder
RJ
Regina Jakacki, MD
CMO
JC
Jianzhu Chen, PhD
Co-founder, Scientific Advisor